Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0010 (-1.69%)
Sep 10, 2026, 4:10 PM AEST
Actinogen Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -15.38 | -14.73 | -13.04 | -10.75 | -9.5 |
Depreciation & Amortization | 0.42 | 0.42 | 0.42 | 0.41 | 0.4 |
Stock-Based Compensation | 1.72 | 1.66 | 1.31 | 1.52 | 1.29 |
Other Operating Activities | 0.41 | 0.01 | -0.02 | -0 | -0.01 |
Change in Accounts Receivable | -5.26 | 3.5 | -5.2 | -0.18 | -2.41 |
Change in Accounts Payable | 0.5 | 1.55 | -0.38 | 0.25 | 0.69 |
Change in Other Net Operating Assets | 0.02 | 0.04 | -0.04 | 0.06 | 0.03 |
Operating Cash Flow | -17.56 | -7.56 | -16.95 | -8.7 | -9.52 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.01 | -0.04 | -0.01 | -0.04 | -0 |
Investing Cash Flow | -0.01 | -0.04 | -0.01 | -0.04 | -0 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 4.32 | 3 | - | - | - |
Total Debt Issued | 4.32 | 3 | - | - | - |
Short-Term Debt Repaid | -3.15 | - | - | - | - |
Long-Term Debt Repaid | -0.07 | -0.06 | -0.09 | -0.08 | -0.07 |
Lease Payments | -0.07 | -0.06 | -0.09 | -0.08 | -0.07 |
Total Debt Repaid | -3.22 | -0.06 | -0.09 | -0.08 | -0.07 |
Net Debt Issued (Repaid) | 1.1 | 2.94 | -0.09 | -0.08 | -0.07 |
Issuance of Common Stock | 17.55 | 12.24 | 19.11 | 0.9 | 13.32 |
Other Financing Activities | -0.85 | -0.53 | -1.06 | - | -0.83 |
Financing Cash Flow | 17.8 | 14.65 | 17.95 | 0.82 | 12.42 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | - | - | - | 0 | 0.01 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0.04 |
Net Cash Flow | 0.23 | 7.05 | 0.99 | -7.91 | 2.95 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -17.57 | -7.59 | -16.96 | -8.73 | -9.52 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -138.63% | -138.33% | -170.76% | -178.70% | -261.53% |
Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -12.54 | -2.49 | -12.2 | -4.86 | -5.98 |
Unlevered Free Cash Flow | -12.25 | -2.46 | -12.18 | -4.85 | -5.97 |
Free Cash Flow After Leases | -17.64 | -7.65 | -17.05 | -8.81 | -9.59 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.02 | 0.04 | 0.02 | 0.02 | 0.01 |
Cash Income Tax Paid | - | - | - | - | -1.43 |
Change in Working Capital | -4.74 | 5.08 | -5.62 | 0.13 | -1.69 |